Navigation Links
minSURG(TM) Corporation Launches International Division
Date:7/18/2008

CLEARWATER, Fla., July 18 /PRNewswire/ -- minSURG Corporation, producers of the TruFUSE(R) percutaneous facet stabilization procedure, announced today the creation of minSURG International, Incorporated. The international division has been established in response to global demand for the TruFUSE procedure and products.

CEO, Jim Doulgeris said, "Distributors from Canada, Brazil, Germany, Greece, South Korea, Netherlands, Singapore, Taiwan, Turkey and Japan have expressed strong interest in providing the benefits of our minimally invasive and percutaneous spinal fusion to their populations suffering from debilitating back pain. Sales to Turkey and Greece have already been initiated."

Peter Sontag, the current Chairman of minSURG's parent company, was appointed as President of the new international division. Sontag's extensive international business experience, having lived abroad for over 22 years, along with his understanding of diverse cultures makes him the ideal candidate for this position. According to Sontag, TruFUSE must respond to the demands of the international marketplace after successfully engaging North America. "The dynamics of numerous medical reimbursement systems around the world are as unique as the languages spoken in their various countries. We will implement dynamic solutions to international distribution parallel to the success we have demonstrated here," Sontag said.

The TruFUSE procedure uses specially designed human bone dowels to stop facet joints from moving, which is intended to eliminate or dramatically reduce back pain caused by a variety of reasons. TruFUSE is also used to supplement other back surgeries when more invasive or destructive means are not required. The TruFUSE procedure is intended to fuse the facet joints through a natural healing process for a long-term solution. Because TruFUSE causes minimal tissue damage, it does not preclude other options, including non-surgical alternatives, and TruFUSE can
'/>"/>

SOURCE minSURG Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Baxa Corporation Launches New Electronic Users Group Web Site
2. Leatt Corporation To Sponsor 2008 South African Motocross Grand Prix
3. China Medicine Corporation Obtains Australian Patent for rADTZ
4. BioElectronics Corporations Commercial Resumes on Bloomberg Television
5. Carnegie Corporation funds ASCB course on parasites for African scientists
6. Posit Science Corporation Releases the Brain Fitness Program Classic(TM) for Mac OS X
7. Conrad A. Conrad Elected Chairman of the Board for Rural/Metro Corporation
8. CRH Medical Corporation opens center in New Orleans, Louisiana
9. Zix Corporation Announces Webcast Showcasing Email Encryption Competitive Replacement
10. Bederra Corporation Retains OTC Financial Network for Investor Relations
11. Triple-S Management Corporation Schedules Second-Quarter Earnings Release and Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)...c. 2 VirtualScopics, Inc...tative imaging for clinical,trials, today announc...,compared to $14.7 million at the same time a year...lculates backlog as the amount remaining to be,re...ration of the studies,included within the backlog...
(Date:12/2/2008)...ew Report Finds Many Cite Prevention, Shedding, or...2 A New Center for Stat...how states are balancing retiree health care plans...ree Health Care in the American States examines h... retiree health care benefits to central human res...
(Date:12/2/2008)... Patients treated with radiation prior to surger...of cancer recurrence and better overall survival r...The report examined a treatment called neoadjuvant... limit the spread of cancer, before surgery to rem...motherapy and/or radiation. , Neoadjuvant thera...
(Date:12/2/2008)...A new report from the Institute of Medicine propos...workloads to decrease the chances of fatigue-relat...ronment for these doctors in training. The report...rk hours from the maximum average of 80 per week s...al Education (ACGME) in 2003, but rather reduces t...
Breaking Medicine News(10 mins):Health News:VirtualScopics Backlog Rises to a Record $27 Million 2Health News:VirtualScopics Backlog Rises to a Record $27 Million 3Health News:States View Limits on Retiree Health Benefits 2Health News:Revised hours and workloads for medical residents needed to prevent 2Health News:Revised hours and workloads for medical residents needed to prevent 3
...are alarmed as new rules are being implemented th...can work// in hospitals of the National Health Se...ctors from the Indian subcontinent who could sudd...e event of a job vacancy if there are no local doc...
...th conscious, but dying from cancer can certainly ...is happen, it would obviously warrant lifestyle ch... nutritious food habits, regular exercise, and scr...study has been enabled by the American Cancer Soci...
... Scottish executives large numbers of Scots is exp...ing. The researchers feel that memory loss is asso...ave young women in vulnerable situations, becoming...eted young people in four cities found that a larg...
...provided some useful tips on prevention of skin ca...ome of its risk factors and treatment. According ...evelopment of skin cancer individuals who have a f... disposition towards developing skin cancer becaus...
Other Medicine News:Health News:Work Permit Required For Indian Doctors in Britain 2Health News:Work Permit Required For Indian Doctors in Britain 3Health News:Did You Know That 50% Of Deaths Due To Cancer, Can be Prevented? 2Health News:Prevent Skin Cancer with Lifestyle Changes 2
(Date:12/1/2008)...swire/ -- New research has found that the availabi... (CT) scanner in an emergency room can significant...ve a potentially life-saving treatment. Results of...r (NSMC)-Salem Hospital in Salem, Mass., will be p...ogical Society of North America (RSNA). , , ...
(Date:12/1/2008)...e-FirstCall/ -- Vanda Pharmaceuticals Inc. (Nasdaq...e of the world,s leading medical journals, results...or, experimental compound tasimelteon (VEC-162). ... "Melatonin agonist tasimelteon (VEC-162) for tran...sed controlled multicentre trials." Results are re...
(Date:12/1/2008)... S*BIO Pte Ltd today announced the initiation of a...orally-active JAK2 inhibitor, in leading medical c...pathic myelofibrosis (CIMF). , , The trial...ty of SB1518 in patients with CIMF and is expected...the study will assess the safety profile and evalu...
(Date:12/1/2008)...reated With ENB-0040 at Children,s Hospital, Healt... Dec. 1 Enobia Pharma, an emerging...vel therapeutics for serious bone disorders, today...inical program for hypophosphatasia was dosed. Eno...RT) with ENB-0040 for the treatment of this rare a...
Breaking Medicine Technology:Portable CT Increases Chance of Stroke Survival and Recovery 2Portable CT Increases Chance of Stroke Survival and Recovery 3Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 2Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 3Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 4S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 2S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 3Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 2Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 3Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 4Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 5Roseland Medical Center Hosts Recognition Ceremony and Open House 16882 1CDC and Retail Health Clinic Leaders Explore Improving Prevention Surveillance and Emergency Response 16880 1CDC and Retail Health Clinic Leaders Explore Improving Prevention Surveillance and Emergency Response 16880 2Calorie restricted diet prevents pancreatic inflammation and cancer 16879 1Calorie restricted diet prevents pancreatic inflammation and cancer 16879 2Marriage for a New World 16877 1Marriage for a New World 16877 2
... Cytogen,Corporation (NASDAQ: CYTO) today reported...the 2007 Annual Meeting of the American,Associatio...ngeles,California April 14-18, 2007. The AACR abs...ate novel approaches to drug,discovery and develop...(TM) (Antigen-Binding pepTIDES) and oral drug deli...
...A Pharmaceuticals,Inc. (Nasdaq: ACAD), a biopharma...o fuel drug discovery and clinical,development of ...ers, today announced that the company will present...ia Research, held from,March 28 through April 1, 2...will cover ACADIA,s two schizophrenia programs and...
Other Medicine Technology:Preclinical Data on Cytogen's Technology to be Reported at the AACR,Annual Meeting 2Preclinical Data on Cytogen's Technology to be Reported at the AACR,Annual Meeting 3Preclinical Data on Cytogen's Technology to be Reported at the AACR,Annual Meeting 4ACADIA Pharmaceuticals' Schizophrenia Programs to Be Presented at,the 2007 International Congress on Schizophrenia Research 2ACADIA Pharmaceuticals' Schizophrenia Programs to Be Presented at,the 2007 International Congress on Schizophrenia Research 3ACADIA Pharmaceuticals' Schizophrenia Programs to Be Presented at,the 2007 International Congress on Schizophrenia Research 4ACADIA Pharmaceuticals' Schizophrenia Programs to Be Presented at,the 2007 International Congress on Schizophrenia Research 5
Stainless steel construction to withstand sterilization modalities (EtO) Wide angle of view
Inquire
ENDOlap™ laparoscopes provide excellent image linearity and flatness of field.
The Fujinon's R410 laparoscope is the first to bring a 410,000 pixel CCD to the end of the scope. Superior imaging and color replication, along with a unique lens washing capability make the R410 the
Medicine Products: